Recall Register

Food, drugs, devices › Animas Corporation

Device recall: IR1200, IR1250(IR1200 Plus), 2020 and One Touch(R) Ping(R) Insulin Pump glucose management system. The device is intende

FDA enforcement event 61780 · Class II · initiated 16 Jul 2012 · status Terminated · terminated 15 Jan 2014

DeviceVoluntary: Firm initiated1 product recordWest Chester, PA

FDA enforcement event 61780 is a device recall by Animas Corporation of West Chester, PA, initiated 16 Jul 2012 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 88% of the 823 device enforcement events initiated in 2012 carry the same class.

Status: Terminated, terminated 15 Jan 2014. Initiation: voluntary: firm initiated. Animas Corporation has 6 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Animas Corporation, West Chester, PA.

Reason for recall

"Wear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump."

Distribution

"Worldwide distribution: USA (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-0005-2013IR1200, IR1250(IR1200 Plus), 2020 and One Touch(R) Ping(R) Insulin Pump glucose management system. The device is intended to deliver insulin therapy.236,470Class IITerminated10 Oct 2012

Context

88%of 2012 device events are Class II823 events that year
1product record in this eventfirm median: 1
6events on this register for the firm

Other enforcement events for Animas Corporation

InitiatedProduct (first record)TypeClassRecords
10 Jun 2014Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treDeviceClass II1
3 Jan 2013Animas(R) 2020 Insulin Infusion Pump Product Usage: This product is indicated for continuous subcutaneous infusion of inDeviceClass I1
17 Dec 2012Animas(R) 2020, Animas(R) IR 1250 (1200 plus), Animas(R) IR 1200 Insulin Infusion Pumps Indicated for continuous subcutaDeviceClass III1
25 Oct 2012Animas Vibe Insulin Infusion Pump and System. These products are indicated for continuous subcutaneous infusion of insulDeviceClass II1
6 Sep 2011Animas Vibe Insulin Infusion Pump. This product is indicated for continuous subcutaneous infusion of insulin for the treDeviceClass II1

All 6 events for Animas Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Wear of the keypad that may lead to damage such as tearing or peeling of the edge of the keypad from the pump."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution: USA (nationwide) including states of: AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 15 Jan 2014. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.